Betafectin data

ABTI (Worcester, Mass.) announced results of its second Phase II study at the Surgical Infectious Society meeting in Toronto.

In 61 patients undergoing major chest or abdominal surgery, those who received the 0.5, 1, and 2 mg/kg doses had a total of 15 infections, as compared to 28 infections in the patients who got placebo or 0.1 mg/kg (p < 0.05). The three highest doses also reduced hospital stays from 12 to 8.5 days (p < 0.03). ...